Therapeutic Compounds

Therapeutics. Compounds containing the furan or tetrahydrofuran ring are biologically active and are present in a number of pharmaceutical products. Eurfurjdamine [617-89-0] is an intermediate in the diuretic, furosemide. Tetrahydrofurfurylamine [4795-29-3] may also have pharmaceutical applications. 5-(E)imethyiaininomethyi)furfuryi alcohol [15433-79-17 is an intermediate in the preparation of ranitidine, which is used for treating ulcers. 2-Acet5dfuran [1192-62-7] prepared from acetic anhydride and furan is an intermediate in the synthesis of cefuroxime, a penicillin derivative. 2-Euroic acid is prepared by the oxidation of furfural. Both furoic acid [88-14-2] and furoyl chloride [527-69-5] are used as pharmaceutical intermediates. 

Table 32.1 describes 30 persons who have been observed to use one of four available therapeutic compounds for the treatment of one of three possible disorders. The four compounds in this measurement table are the benzodiazepine tranquillizers Clonazepam (C), Diazepam (D), Lorazepam (L) and Triazolam (T). The three disorders are anxiety (A), epilepsy (E) and sleep disturbance (S). In this example, both measurements (compounds and disorders) are defined on nominal scales. Measurements can also be defined on ordinal scales, or on interval and ratio scales in which case they need to be subdivided in discrete and non-overlapping categories. 

Furthermore, it has been observed that placental PGP is of great importance in limiting the fetal penetration of various potentially harmful or therapeutic compounds [64]. High PGP levels may have a role in the protection of fetuses from harmful tropical plant metabolites (from which many drugs are derived). An originally balanced polymorphism may have been preferentially selected by improved prenatal growth and development as well as improved postnatal health. This selective pressure may maintain the C allele in populations of African descent. 

In recent years, CNTs have been receiving considerable attention because of their potential use in biomedical applications. Solubility of CNTs in aqueous media is a fundamental prerequisite to increase their biocompatibility. For this purpose several methods of dispersion and solubilisation have been developed leading to chemically modified CNTs (see Paragraph 2). The modification of carbon nanotubes also provides multiple sites for the attachment of several kinds of molecules, making functionalised CNTs a promising alternative for the delivery of therapeutic compounds. 

Calu-3 (American type culture collection ATCC HTB-55) is a human bronchial epithelial cell line derived from an adenocarcinoma of the lung [59], This cell line has been shown to exhibit serous cell properties and form confluent monolayers of mixed cell phenotypes, including ciliated and secretory cell types [60], but the cilia are formed very irregularly and seem to disappear with increasing passage number (unpublished observations, C.E. and B.F.). Calu-3 cells have shown utility as a model to examine transport [61-63] and metabolism in human bronchial epithelial cells for many therapeutic compounds [64], Furthermore, they have been used in a number of particlecell interaction studies [65-67], The interactions between respiratory epithelial cells and particulates are discussed more in detail in Chap. 19. 

Hogg RC, Bertrand D (2004) Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds. Bioorganic Med Chem Lett 14 1859-1861... 

Example 22 removal of allyl group attached to a phosphorus centre with Pd, Pt and Rh complexes is a well established procedure [51] but is inconvenient for synthesis of therapeutic compounds on a large scale. During the deprotection step the palladium catalyst is susceptible to poisoning especially with P-S compounds resulting in loss of catalytic efficiency. Furthermore traces of organometallic compounds remain in the product after deprotection. In the paper of Manoharan et al. other methods of deprotection of allyl... 

All the previous prediction methods outlined above only deal with the partitioning of the neutral form of the solute. However, most of therapeutic compounds possess ionizable functions and therefore dissociation equilibria in solution have to be considered for their partitioning in biphasic media. The importance of partitioning... 

Therapeutic Compound/Chemical class/Structure area... 

---